REPROSENT
YC S21San Francisco, US · Founded 2020 · 4 employees · 1 known investors
REPROSENT captures patient treatment experience data to support dose, safety, and development decisions in oncology and advanced cancer therapies. The platform operates as a lightweight, non-interventional overlay on existing clinical trials and care programs, converting patient symptoms into structured, computable signal for development and clinical teams.
BiotechDigital HealthHealthtechMedical DevicesBiometricsConsumer Health ServicesHealthcareOncologyUnited States of AmericaAmerica / CanadaFully Remote
Founders & leadership· Y Combinator alumni (S21)
REPROSENT was founded in 2020 by Aimee DeGolyer and Michael Sample.
AD
Aimee DeGolyerinFounder & CEOAimee DeGolyer previously worked at Ciitizen in oncology patient data and founded multiple companies including True Key, OnCue, and LightLogic. She started REPROSENT following personal experience with her father's death from a treatment-related adverse reaction.
MS
Michael SampleinCo-founder · Chief Technology OfficerHe has previously built software solutions for consumer startups and enterprise companies.
Investors · 1
Images
Frequently asked questions
- What does REPROSENT do?
- REPROSENT captures patient treatment experience data to support dose, safety, and development decisions in oncology and advanced cancer therapies. The platform operates as a lightweight, non-interventional overlay on existing clinical trials and care programs, converting patient symptoms into structured, computable signal for development and clinical teams.
- Who founded REPROSENT?
- REPROSENT was founded by Aimee DeGolyer, Michael Sample in 2020.
- Who are REPROSENT's investors?
- REPROSENT's investors include Y Combinator.
- Where is REPROSENT headquartered?
- REPROSENT is headquartered in San Francisco, US.